Compounds exhibiting 3alpha-hydroxy-5alpha/beta-steroid blocking action withno or only low antagonism against the gamma-aminobutyric acid (A) receptor(GABA-A), and compounds exhibiting partial antagonism against said receptorare presented. Methods for the prevention, treatment and/or alleviation ofvarious CNS-disorders are suggested, as well as pharmaceutical compositionsfor such use.